Skip to content

“Technically, you know, Novo Nordis has not actually lost…” — The Daily at 15:35

“Technically, you know, Novo Nordis has not actually lost its patent, but it is an unusual situation in the sense that because of this shortage, the federal law does allow companies to produce versions of a patented drug. And so while we have seen this before and it's happened with other drugs, what analysts tell me…”

0:00 22:34